Analytical Data
-
Gene name
FLJ22167
- Application
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H6L2
-
Expression Region
1-316aa
-
AA Sequence
MALYELFSHPVERSYRAGLCSKAALFLLLAAALTYIPPLLVAFRSHGFWLKRSSYEEQPTVRFQHQVLLVALLGPESDGFLAWSTFPAFNRLQGDRLRVPLVSTREEDRNQDGKTDMLHFKLELPLQSTEHVLGVQLILTFSYRLHRMATLVMQSMAFLQSSFPVPGSQLYVNGDLRLQQKQPLSCGGLDARYNISVINGTSPFAYDYDLTHIVAAYQERNVTTVLNDPNPIWLVGRAADAPFVINAIIRYPVEVISYQPGFWEMVKFAWVQYVSILLIFLWVFERIKIFVFQNQVVTTIPVTVTPRGDLCKEHLS
-
Molecular Weight
62.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FLJ22167, designated as a novel recombinant protein, has garnered significant attention in biomedical research due to its potential therapeutic applications and involvement in various cellular processes. Initially identified through systematic gene sequencing efforts, this protein is believed to play a crucial role in regulating immune responses, cell signaling, and potentially influencing metabolic pathways. Studies have indicated that FLJ22167 may exhibit associations with certain pathologies, including autoimmune diseases and cancers, prompting investigators to explore its structural characteristics and functional dynamics. The protein's unique features allow for the development of specific antibodies and diagnostic tools, making it a promising candidate for further investigation in targeted therapies. As the scientific community delves deeper into its mechanisms of action, FLJ22167 is positioned at the forefront of research aimed at uncovering new strategies for disease management and therapeutic intervention, highlighting the importance of understanding novel proteins in the quest for advanced medical solutions.
